Cargando…
Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test
BACKGROUND: Intervention guidelines against Schistosoma mansoni are based on the Kato-Katz technique. However, Kato-Katz thick smears show low sensitivity, especially for light-intensity infections. The point-of-care circulating cathodic antigen (POC-CCA) is a promising rapid diagnostic test detecti...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310297/ https://www.ncbi.nlm.nih.gov/pubmed/30550594 http://dx.doi.org/10.1371/journal.pntd.0006941 |
_version_ | 1783383414781509632 |
---|---|
author | Bärenbold, Oliver Garba, Amadou Colley, Daniel G. Fleming, Fiona M. Haggag, Ayat A. Ramzy, Reda M. R. Assaré, Rufin K. Tukahebwa, Edridah M. Mbonigaba, Jean B. Bucumi, Victor Kebede, Biruck Yibi, Makoy S. Meité, Aboulaye Coulibaly, Jean T. N’Goran, Eliézer K. Tchuem Tchuenté, Louis-Albert Mwinzi, Pauline Utzinger, Jürg Vounatsou, Penelope |
author_facet | Bärenbold, Oliver Garba, Amadou Colley, Daniel G. Fleming, Fiona M. Haggag, Ayat A. Ramzy, Reda M. R. Assaré, Rufin K. Tukahebwa, Edridah M. Mbonigaba, Jean B. Bucumi, Victor Kebede, Biruck Yibi, Makoy S. Meité, Aboulaye Coulibaly, Jean T. N’Goran, Eliézer K. Tchuem Tchuenté, Louis-Albert Mwinzi, Pauline Utzinger, Jürg Vounatsou, Penelope |
author_sort | Bärenbold, Oliver |
collection | PubMed |
description | BACKGROUND: Intervention guidelines against Schistosoma mansoni are based on the Kato-Katz technique. However, Kato-Katz thick smears show low sensitivity, especially for light-intensity infections. The point-of-care circulating cathodic antigen (POC-CCA) is a promising rapid diagnostic test detecting antigen output of living worms in urine and results are reported as trace, 1+, 2+, and 3+. The use of POC-CCA for schistosomiasis mapping, control, and surveillance requires translation of the Kato-Katz prevalence thresholds into POC-CCA relative treatment cut-offs. Furthermore, the infection status of egg-negative but antigen-positive individuals and the intensity-dependent sensitivity of POC-CCA should be estimated to determine its suitability for verification of disease elimination efforts. METHODOLOGY: We used data from settings in Africa and the Americas characterized by a wide range of S. mansoni endemicity. We estimated infection intensity-dependent sensitivity and specificity of each test at the unit of the individual, using a hierarchical Bayesian egg-count model that removes the need to define a ‘gold’ standard applied to data with multiple Kato-Katz thick smears and POC-CCA urine cassette tests. A simulation study was carried out based on the model estimates to assess the relation of the two diagnostic tests for different endemicity scenarios. PRINCIPAL FINDINGS: POC-CCA showed high specificity (> 95%), and high sensitivity (> 95%) for moderate and heavy infection intensities, and moderate sensitivity (> 75%) for light infection intensities, and even for egg-negative but antigen-positive infections. A 10% duplicate slide Kato-Katz thick smear prevalence corresponded to a 15–40% prevalence of ≥ trace-positive POC-CCA, and 10–20% prevalence of ≥ 1+ POC-CCA. The prevalence of ≥ 2+ POC-CCA corresponded directly to single slide Kato-Katz prevalence for all prevalence levels. CONCLUSIONS/SIGNIFICANCE: The moderate sensitivity of POC-CCA, even for very light S. mansoni infections where the sensitivity of Kato-Katz is very low, and the identified relationship between Kato-Katz and POC-CCA prevalence thresholds render the latter diagnostic tool useful for surveillance and initial estimation of elimination of S. mansoni. For prevalence below 10% based on a duplicate slide Kato-Katz thick smear, we suggest using POC-CCA including trace results to evaluate treatment needs and propose new intervention thresholds that need to be validated in different settings. |
format | Online Article Text |
id | pubmed-6310297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-63102972019-01-08 Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test Bärenbold, Oliver Garba, Amadou Colley, Daniel G. Fleming, Fiona M. Haggag, Ayat A. Ramzy, Reda M. R. Assaré, Rufin K. Tukahebwa, Edridah M. Mbonigaba, Jean B. Bucumi, Victor Kebede, Biruck Yibi, Makoy S. Meité, Aboulaye Coulibaly, Jean T. N’Goran, Eliézer K. Tchuem Tchuenté, Louis-Albert Mwinzi, Pauline Utzinger, Jürg Vounatsou, Penelope PLoS Negl Trop Dis Research Article BACKGROUND: Intervention guidelines against Schistosoma mansoni are based on the Kato-Katz technique. However, Kato-Katz thick smears show low sensitivity, especially for light-intensity infections. The point-of-care circulating cathodic antigen (POC-CCA) is a promising rapid diagnostic test detecting antigen output of living worms in urine and results are reported as trace, 1+, 2+, and 3+. The use of POC-CCA for schistosomiasis mapping, control, and surveillance requires translation of the Kato-Katz prevalence thresholds into POC-CCA relative treatment cut-offs. Furthermore, the infection status of egg-negative but antigen-positive individuals and the intensity-dependent sensitivity of POC-CCA should be estimated to determine its suitability for verification of disease elimination efforts. METHODOLOGY: We used data from settings in Africa and the Americas characterized by a wide range of S. mansoni endemicity. We estimated infection intensity-dependent sensitivity and specificity of each test at the unit of the individual, using a hierarchical Bayesian egg-count model that removes the need to define a ‘gold’ standard applied to data with multiple Kato-Katz thick smears and POC-CCA urine cassette tests. A simulation study was carried out based on the model estimates to assess the relation of the two diagnostic tests for different endemicity scenarios. PRINCIPAL FINDINGS: POC-CCA showed high specificity (> 95%), and high sensitivity (> 95%) for moderate and heavy infection intensities, and moderate sensitivity (> 75%) for light infection intensities, and even for egg-negative but antigen-positive infections. A 10% duplicate slide Kato-Katz thick smear prevalence corresponded to a 15–40% prevalence of ≥ trace-positive POC-CCA, and 10–20% prevalence of ≥ 1+ POC-CCA. The prevalence of ≥ 2+ POC-CCA corresponded directly to single slide Kato-Katz prevalence for all prevalence levels. CONCLUSIONS/SIGNIFICANCE: The moderate sensitivity of POC-CCA, even for very light S. mansoni infections where the sensitivity of Kato-Katz is very low, and the identified relationship between Kato-Katz and POC-CCA prevalence thresholds render the latter diagnostic tool useful for surveillance and initial estimation of elimination of S. mansoni. For prevalence below 10% based on a duplicate slide Kato-Katz thick smear, we suggest using POC-CCA including trace results to evaluate treatment needs and propose new intervention thresholds that need to be validated in different settings. Public Library of Science 2018-12-14 /pmc/articles/PMC6310297/ /pubmed/30550594 http://dx.doi.org/10.1371/journal.pntd.0006941 Text en © 2018 Bärenbold et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Bärenbold, Oliver Garba, Amadou Colley, Daniel G. Fleming, Fiona M. Haggag, Ayat A. Ramzy, Reda M. R. Assaré, Rufin K. Tukahebwa, Edridah M. Mbonigaba, Jean B. Bucumi, Victor Kebede, Biruck Yibi, Makoy S. Meité, Aboulaye Coulibaly, Jean T. N’Goran, Eliézer K. Tchuem Tchuenté, Louis-Albert Mwinzi, Pauline Utzinger, Jürg Vounatsou, Penelope Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test |
title | Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test |
title_full | Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test |
title_fullStr | Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test |
title_full_unstemmed | Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test |
title_short | Translating preventive chemotherapy prevalence thresholds for Schistosoma mansoni from the Kato-Katz technique into the point-of-care circulating cathodic antigen diagnostic test |
title_sort | translating preventive chemotherapy prevalence thresholds for schistosoma mansoni from the kato-katz technique into the point-of-care circulating cathodic antigen diagnostic test |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310297/ https://www.ncbi.nlm.nih.gov/pubmed/30550594 http://dx.doi.org/10.1371/journal.pntd.0006941 |
work_keys_str_mv | AT barenboldoliver translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT garbaamadou translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT colleydanielg translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT flemingfionam translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT haggagayata translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT ramzyredamr translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT assarerufink translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT tukahebwaedridahm translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT mbonigabajeanb translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT bucumivictor translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT kebedebiruck translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT yibimakoys translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT meiteaboulaye translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT coulibalyjeant translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT ngoraneliezerk translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT tchuemtchuentelouisalbert translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT mwinzipauline translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT utzingerjurg translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest AT vounatsoupenelope translatingpreventivechemotherapyprevalencethresholdsforschistosomamansonifromthekatokatztechniqueintothepointofcarecirculatingcathodicantigendiagnostictest |